DDReg Pharma Pvt. Ltd. has been shortlisted for the ‘Regulatory’ category by CPHI for their entry on Technology-Enabled Regulatory Services through Vitalic® . This recognition is a testament to DDReg's commitment to innovation and excellence in an industry where compliance and regulatory affairs are paramount. With approximately 45,000 attendees, 1,800+ exhibitors, and participation from over 170 countries, CPHI provides the platform for forging connections, sharing knowledge, and propelling the pharmaceutical industry forward. It offers a hub for learning, networking, and collaboration where industry leaders gather to discuss the latest trends, technologies, and innovations.
Celebrating Excellence: The CPHI Pharma Awards 2023
At the heart of CPHI lies a deep appreciation for excellence in the pharmaceutical industry. The CPHI Pharma Awards 2023 serve as a testament to this commitment and recognize influencers in the industry who have made remarkable contributions to the field. Over the past twenty years, these awards have not only recognized outstanding companies but also individuals who have emerged as shining examples of excellence within the pharmaceutical sector. These winners have been acknowledged for their noteworthy contributions in propelling the industry forward, encompassing their efforts in people, products, and performance. The selection of finalists for the CPHI Pharma Awards 2023 involves a meticulous and thorough process. From an initial pool of over 180 submissions spanning 12 categories that showcase innovations throughout the entire pharmaceutical supply chain, a carefully curated shortlist emerges. This shortlist comprises a mix of industry titans with well-established reputations and emerging companies that are redefining the boundaries of what can be achieved.
DDReg Pharma Pvt. Ltd: Nominated for Technology-Enabled Regulatory Services
DDReg Pharma Pvt. Ltd. has been nominated under the ‘Regulatory’ category for their entry on Technology-Enabled Regulatory Services through Vitalic®. Vitalic® is a cloud-based platform that automates and streamlines regulatory affairs processes, to deliver efficiency for regulatory submissions. It reduces time-to-market, cost & resource expenditure, and risk of non-compliance. Technology-enabled solutions are the need of the hour particularly for regulatory affairs to streamline laborious activities.
Traditionally, regulatory affairs services has been a resource-heavy, manual, and painstaking area involving repetitive work. Systems that work in siloes can create inefficiencies thereby delaying product submissions and subsequent market access. With regulations changing so frequently for different regions, it can be difficult for pharmaceutical organizations to stay updated with such dynamic regulations and incorporate them into their submissions. This may lead to an increased risk of application rejection and can have significant impact on an organization’s financial status and reputation in the market.
Vitalic® offers a unique combination of project management with document management and regulatory information management system (RIMS Software); it facilitates project management by allowing efficient project allocation to resources, multiple levels of project working, and allows complete tracking & monitoring or projects on real time basis while maintain a complete audit trail. Amongst its many features, Vitalic® is supported by an intel base of over 120 regulatory agencies. It reduces manual labour by around 80% to enhance efficiencies in regulatory submissions and management for a diverse range of therapeutics (i.e., generics, complex generics, biologics, biosimilars, medical devices & combination products, cosmetics). It supports pharmaceutical organizations in devising robust regulatory strategies for their target markets including whitespace markets or unfamiliar regions.
The web-based proprietary tool is indeed a testament to DDReg's commitment to innovation and excellence in the field of regulatory affairs. It has helped pharmaceutical services companies to reduce costs, improve efficiency, and accelerate the time to market for their products. DDReg's nomination for the CPHI Pharma Awards is a well-deserved recognition of its efforts to make regulatory affairs more efficient and effective for pharmaceutical services companies.
The company's Vitalic® platform is a valuable tool that is helping to shape the future of regulatory affairs in the pharmaceutical industry. As DDReg looks forward to the 2023 edition of CPHI Barcelona, it's clear that this event will once again set the stage for ground-breaking developments and collaborations in the world of pharmaceuticals.
DDReg is a globally renowned Regulatory and Pharmacovigilance service provider that was founded in 2009. It is headquartered in Gurugram, Haryana- also known as the Millenium City of India- with operating offices in the cities of Mumbai and Hyderabad, and a virtual office in Wilmington, Delaware.
DDReg has worked alongside over 120 regulatory agencies and submitted over 1700 filings in regulated and emerging markets. These include USA, EU, UK, GCC, MENA, LatAM, APAC, and CIS. Its niche product area of expertise includes generics, biologics, biosimilars, consumer products, and medical devices. In addition to Regulatory Affairs, DDReg has provided its customers with comprehensive support for Pharmacovigilance- including ICSR Processing & Submission, local QPPV/LSR, Literature Monitoring, Signal Management- Medico-Regulatory & Safety Writing, Strategic and Regulatory Intelligence Advisory Services, Publishing, Labeling, Artwork Management, IPR, Audits, Clinical & Regulatory Reports, Certification Services for Regulatory Submissions, and more.